Hologic Appoints Wayde McMillan to Board, Strengthening Leadership in Women's Health Innovation
- Hologic appoints Wayde McMillan to its Board of Directors, effective April 4, 2025, enhancing leadership in women's health.
- McMillan brings extensive finance and healthcare management experience, previously serving as CFO at Solventum and 3M's Health Care Group.
- Hologic aims to strengthen its strategic vision and product offerings with McMillan's expertise amid evolving medical technology challenges.
Hologic Strengthens Leadership with Appointment of Wayde McMillan to Board of Directors
Hologic, Inc., a prominent player in the medical technology sector focused on enhancing women’s health, has announced the election of Wayde McMillan to its Board of Directors, set to take effect on April 4, 2025. McMillan, who will also join the Audit and Finance Committee, brings a robust background in finance and healthcare management. His most recent role was as Chief Financial Officer at Solventum Corporation, a healthcare company that emerged from 3M. Prior to that, he served as CFO for 3M’s Health Care Business Group, a position he held since November 2023. His extensive career also includes significant roles at Insulet Corporation and Medtronic plc, where he led the Minimally Invasive Therapies Group and held various financial leadership positions at Covidien before its acquisition by Medtronic.
Steve MacMillan, Hologic's Chairman, President, and CEO, expresses enthusiasm over McMillan's election, underscoring that his financial expertise and extensive knowledge of the healthcare sector are assets that will greatly enhance the Board's capabilities. McMillan holds a Bachelor of Science in Business Administration from Merrimack College and an MBA from Bentley University's McCallum Graduate School of Business. His diverse experience positions him as a key figure in helping Hologic navigate the complexities of the evolving medical technology landscape, particularly as the company remains committed to its mission of advancing women's health through innovative early detection and treatment solutions.
Hologic’s decision to bolster its leadership team comes at a time when the medical technology sector faces increasing competition and rapid advancements. The company’s proactive approach to securing experienced professionals like McMillan reflects its strategic commitment to maintaining a strong foundation. However, Hologic acknowledges that this announcement involves forward-looking statements that carry inherent risks and uncertainties, particularly regarding the challenges associated with recruiting qualified board members and executives. As Hologic continues to prioritize women's health, the integration of McMillan's expertise into its strategic vision signals a promising direction for the company.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

